The IPO for Affimed Therapeutics (NASDAQ: AFMD) opened for trading at $6.90 after pricing 8,000,000 common shares at an initial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE